Human immunodeficiency virus type-1 susceptible whole cell and microcell hybrids

Annals of Clinical and Laboratory Science

Volumn 26, Issue 6, 1996, Pages 522-530

  Harrington, Robert D ^a,c   Geballe, Adam P ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL CLONING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYBRID CELL; HYBRID GENE; HYBRIDIZATION; INFECTION SENSITIVITY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS RESISTANCE;

ANTIGENS, CD26; ANTIGENS, CD4; BLOTTING, NORTHERN; CELL FUSION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIV-1; HUMANS; HYBRID CELLS; TUMOR CELLS, CULTURED;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 0029827760     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Klatzman D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-8.
2. Dalgleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-6.
3. Stein BS, Gowda SD, Lifson JD, Penhallow RC, Bensch KG, Engleman EG. pH-Independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 1987;49:659-68.
4. Gallaher WR. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 1987;50: 327-8.
5. Clapham PR, Blanc D, Weiss RA. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 1991;181:703-15.
6. Linsey PS, Ledbetter JA, Kinney-Thomas E, Hu SL. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J Virol 1988;62:3695-702.
7. Skinner MA, Langlois AJ, McDanal CB, McDougal JS, Bolognesi DP, Matthews TJ. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol 1988;62:4195-200.
8. Hwang SS, Boyle TJ, Lyerly K, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-4.
9. Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schultz TF, Clapham PR, McKeating JA, McClure MO, Thompson S, Marsh M, Kay J, Weiss RA, Moore JP. The V3 loop of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: A possible function in viral fusion? AIDS Res Hum Retroviruses 1991;1:3-16.
10. Andersen KB. Leupeptin inhibits retrovirus infection in mouse fibroblasts. J Virol 1983;48: 765-9.
11. Appleyard G, Tisdale M. Inhibition of the growth of human coronovirus 229E by leupeptin. J Gen Virol 1985;66:363-6.
12. Andersen KB. Cleavage fragments of the retrovirus surface protein gp70 during virus entry. J Gen Virol 1987;68:2193-202.
13. Andersen KB, Skov H. Retrovirus-induced cell fusion is enhanced by protease treatment. J Gen Virol 1989;70:1921-7.
14. Chesebro B, Buller R, Portis J, Wehrly K. Failure of human immunodeficiency virus entry in CD4-positive human brain and skin cells. J Virol 1990;64:215-21.
15. Dragic T, Charneau P, Clavel F, Alizon M. Complementation of murine cells for human immunodeficiency virus envelope/ CD4-mediated fusion in human/murine heterokaryons. J Virol 1992;66:4794-802.
16. Harrington RD, Geballe AP. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol 1993;67:5939-47.
17. Dragic T, Alizon M. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2. J Virol 1993;67:2355-9.
18. Weiner DB, Hubner K, Williams WV, Greene MI. Species tropism of HIV-1 infectivity of interspecific cell hybridomas implies non-CD4 structures are required for cell entry. Cancer Detect Prev 1990;14:317-20.
19. Ramarli D, Cambiaggi C, De Giuli Morghen C, Tripputi P, Ortolani R, Bolzanelli M, Tridente G, Accolla RS. AIDS Res Hum Retroviruses 1993;9:1269-75.
20. Hildreth JEK, Orentas RJ. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 1989; 244:1075-9
21. Sato AI, Balamuth FB, Ugen KE, Williams WV, Weiner DB. Identification of CD7 glycoprotein as an accessory molecule in HIV-1 mediated syncytium formation and cellfree infection J Immunol 1994;152:5142-52.
22. Qureshi NM, Coy DH, Garry RF, Henderson LA. Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS 1990;4: 553-8.
23. Chen YH, Ebenbichler C, Vornhagen R, Schulz TF, Steindl F, Bock G, Katinger H, Dierich MP. HIV gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9. AIDS 1992;6:533-9.
24. Ebenbichler CF, Roder C, Vornhagen R, Ratner L, Dierich MP. Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins. AIDS 1993;7:489-95.
25. Callebaut C, Krust B, Jacotot E, Hovanessian AG. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 1993;262:2045-50
26. Broder CC, Nussbaum O, Gutheil WG, Bachovchin WW, Berger EA. CD26 antigen and HIV fusion? Science 1994;264:1156-9.
27. Patience C, Mcknight A, Clapham PR, Boyd MT, Weiss RA, Schulz TF. CD26 antigen and HIV fusion? Science 1994;264:1159-60.
28. Camerini D, Planelles V, Chen ISY. CD26 antigen and HIV fusion? Science 1994;264:1160-1.
29. Alizon M, Dragic T. CD26 antigen and HIV fusion? Science 1994;264:1161-2.
30. Fatini J, Yahi N, Delezay O, Gonzalez-Scarano F. GalCer, CD26 and HIV infection of intestinal epithelial cells. AIDS 1994;8:1347-8.
31. Werner A, Mattern T, Ulmer AJ, Flad HD, Kurth R, Baier M. CD26 is not required for infection of the lymphoma cell line C8166 with HIV-1. AIDS 1994;8:1348-9.
32. West WHL, Scott E. Cell surface expression of CD26 does not correlate with susceptibility to immunodeficiency viruses. AIDS 1994;8:1349-50.
33. Lazaro I, Naniche D, Signoret N, Bernard AM, Marguet D, Klatzmann D, Dragic T, Alizon M, Sattentau Q. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. J Virol 1994;68:6535-46.
34. Feng Y, Broder C, Kennedy P, Berger E. HIV-1 entry cofactor: functional c-DNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-77.
35. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 1992;66:2232-9.
36. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973;52:456-67.
37. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990;18:3587-96.
38. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993;217:581-99.
39. Garcia JV, Miller AD. Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes. AIDS Res Hum Retroviruses 1994; 10:47-52.
40. Langston AA, Fournier REK. Preparation and properties of microcell hybrids. Methods Mol Genetics 1993;1:115-33.
41. Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C. Cloning and functional expression of the T cell activation antigen CD26. J Immunol 1992;149:481-6.
42. Geballe AP, Leach FS, Mocarski ES. Regulation of cytomegalovirus late gene expression: γ genes are controlled by posttranscriptional events. J Virol 1986;57:864-74.
43. Broder CC, Dimiter DS, Blumenthal R, Berger EA. The block to HIV-1 envelope glycoprotein-mediated fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 1993;193:483-91.
44. Dragic T, Picard L, Alizon M. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1995;69:1013-8.